Heyl Pharma

Heyl Pharma, officially known as Heyl Chemisch-pharmazeutische Fabrik, is a family-owned pharmaceutical company based in Berlin, Germany, with a history dating back to 1926. The company specializes in the development and production of antidotes for heavy metal poisoning and radiation contamination, as well as treatments for rare metabolic disorders like Wilson's disease. Heyl is globally recognized for its expertise in chelation therapy, providing essential medications such as Radiogardase (Prussian blue) and various formulations of penicillamine and trientine. In addition to its core focus on toxicology and metabolic diseases, the company maintains a presence in the rheumatology and infectious disease sectors, serving as a critical supplier for national emergency stockpiles worldwide.